We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Akcea Therapeutics Inc in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 98 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 98 → 0 (-98)

100% less capital invested

Capital invested by funds: $287M → $0 (-$287M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 98

Holders
–
Holders Change
-98
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
98
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$104M
2
BlackRock
BlackRock
New York
-$39.9M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$24.9M
4
GF
Gabelli Funds
New York
-$10.9M
5
Wells Fargo
Wells Fargo
California
-$8.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
26
SG Americas Securities
New York
– -$1.3M -71,598 Closed
Bank of New York Mellon
27
Bank of New York Mellon
New York
– -$1.28M -70,588 Closed
MFAM
28
Motley Fool Asset Management
Virginia
– -$1.27M -70,312 Closed
KPF
29
K2 Principal Fund
Ontario, Canada
– -$1.07M -58,853 Closed
CC
30
Centiva Capital
New York
– -$907K -50,000 Closed
Walleye Capital
31
Walleye Capital
New York
– -$893K -49,226 Closed
Swiss National Bank
32
Swiss National Bank
Switzerland
– -$818K -45,100 Closed
PPA
33
Parametric Portfolio Associates
Washington
– -$812K -44,776 Closed
VEA
34
Virtus ETF Advisers
New York
– -$795K -43,813 Closed
AllianceBernstein
35
AllianceBernstein
Tennessee
– -$780K -43,000 Closed
Barclays
36
Barclays
United Kingdom
– -$696K -38,334 Closed
CCM
37
Chicago Capital Management
Illinois
– -$688K -37,931 Closed
California Public Employees Retirement System
38
California Public Employees Retirement System
California
– -$685K -37,754 Closed
NAM
39
Nexpoint Asset Management
Texas
– -$670K -36,953 Closed
HM
40
Harvest Management
New York
– -$653K -36,000 Closed
PCM
41
Prelude Capital Management
New York
– -$555K -30,618 Closed
ZCM
42
Ziegler Capital Management
Illinois
– -$500K -27,567 Closed
Citadel Advisors
43
Citadel Advisors
Florida
– -$470K -25,890 Closed
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
– -$452K -24,900 Closed
CM
45
Caption Management
Oklahoma
– -$435K -24,000 Closed
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
– -$408K -22,512 Closed
Jane Street
47
Jane Street
New York
– -$381K -21,001 Closed
Dimensional Fund Advisors
48
Dimensional Fund Advisors
Texas
– -$362K -19,950 Closed
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
– -$352K -19,400 Closed
WAM
50
Wolverine Asset Management
Illinois
– -$348K -19,194 Closed
1
2
3 4

AKCA Hedge Fund Activity: Q4 2020 in Review

0 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q4 2020, worth a combined $0 — down 100% from $287M a quarter earlier.

Sellers outnumbered buyers: 98 funds closed out of AKCA and 0 opened new positions — a net loss of 98 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $104M sold.

  • 0 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q4 2020, down from 98 in Q3 2020.
  • Funds reported $0 of Akcea Therapeutics Inc stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Akcea Therapeutics Inc positions in Q4 2020 and 98 closed out, a net change of -98 holders.
  • The largest Akcea Therapeutics Inc seller in Q4 2020 was Fidelity Investments, an estimated $104M sold.

Based on aggregated 13F filings for Q4 2020.